Pharmaceuticals
Alvotech and Cipla Gulf Enter Into a Partnership for the Commercialization of Key Biosimilar in Select Emerging Markets
REYKJAVIK, Iceland and MUMBAI, India, July 29, 2019 /PRNewswire/ -- Biopharmaceutical company Alvotech and Cipla Gulf FZ LLC ("Cipla Gulf"), a wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited (BSE: 500087) (NSE: CIPLA EQ; hereafter referred to as "Cipla"), today ...
2019-07-29 12:00
5570
NeuroVive's NeuroSTAT Project Receives FDA Fast Track Designation
LUND, Sweden, July 28, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the company's candidate drug NeuroSTAT, in development for treatment of moderate to severe traumatic brain injury, TBI, has received Fast Track designation from the ...
2019-07-28 21:47
5608
China Biologic Products to Report Second Quarter 2019 Financial Results
BEIJING, July 26, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release its second quarter 2019 financial resu...
2019-07-27 04:30
10359
Sanofi Announces Participation in 2nd China International Import Expo
SHANGHAI, July 26, 2019 /PRNewswire/ -- At today's Matchmaking Meeting for Medical Devices and Medical Health Care Exhibitors and Buyers of the 2nd China International Import Expo (CIIE), Sanofi officially announced that it would participate in the 2nd CIIE held in the National Convention and Exh...
2019-07-26 21:50
3784
Novartis, Mundipharma ink partnership to enhance access to three Asian countries to established medicine brands for glaucoma and external eye diseases
* Novartis and Mundipharma have signed an agreement for Mundipharma to market, sell and distribute Novartis medicines in the general ophthalmology disease area, including medicines for glaucoma and external eye diseases in Taiwan. This follows recent agreements for the Philippines and Thailand. ...
2019-07-26 12:25
2582
Penta and CROMSOURCE Announce Their Partnership to Improve Paediatric Drug Development
VERONA, Italy, July 25, 2019 /PRNewswire/ -- Penta ID Innovation, a recently established SMO stemmed from the Penta Global Paediatric Research Network, and CROMSOURCE, an international contract research organization (CRO) providing a comprehensive portfolio of services to the pharmaceutical, biot...
2019-07-25 19:00
3344
First Patient Dosed in Sintilimab and Anti-VEGF Monoclonal Antibody IBI305 with Chemotherapy in Patients with EGFR-mutant Non-squamous NSCLC who have Progressed from Prior EGFR-TKI Treatment
SUZHOU, China, July 25, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality innovative medicines for the treatment of oncology, autoimmune and other major diseases, today announ...
2019-07-25 08:16
3194
NanoCellect Biomedical Expands Distribution to Australia and New Zealand
Company enters exclusive agreement with Millennium Science Pty Ltd SAN DIEGO, California, July 24, 2019 /PRNewswire/ -- NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, today announced an exclusive agreement wit...
2019-07-24 21:57
1762
111 Signs Strategic Cooperation with Harbin Pharmaceutical Group
SHANGHAI, July 24, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced the signing of a strategic cooperation agreement with Harbin Pharmaceutical Group Holding Co., Ltd. (HPGC, SHSE: 600664), which has...
2019-07-24 20:00
8229
SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent
TIANJIN, China, July 23, 2019 /PRNewswire/ -- In a significant milestone toward obtaining key regulatory approvals for the BuMA Supreme Drug-Eluting Stent (DES) System, SINOMED has completed enrollment in the PIONEER III randomized, controlled clinical trial. The PIONEER III trial is designed to...
2019-07-23 15:00
2888
Huge CPhI & P-MEC China a direct result of surging manufacturing
SHANGHAI, July 23, 2019 /PRNewswire/ -- CPhI and P-MEC China – organized by China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE), Informa Markets, andShanghai Sinoexpo Informa Markets – saw record numbers of attendees as the pharma market inChina continues to gr...
2019-07-23 13:18
2309
WuXi STA Shanghai & Changzhou Facilities Pass U.S. FDA Inspections
SHANGHAI, July 23, 2019 /PRNewswire/ -- STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – announces that its Analytical Service Unit (ASU) inShanghai and active pharmaceutical ingredient (API) process R&D and manufacturing facility in Changzhou, have successfully passed two...
2019-07-23 12:48
3416
CStone receives approval in China to initiate ivosidenib Phase I bridging registrational study for the treatment of IDH1 mutant relapsed or refractory AML
SUZHOU, China, July 22, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone"; HKEX: 2616) announced today that it has received approval from China National Medical Products Administration (NMPA) to initiate a Phase I bridging registrational study of ivosidenib (TIBSOVO) for the treatment of rela...
2019-07-22 12:17
7222
Ascentage Pharma to Initiate Phase Ib Study of HQP1351 in Tyrosine Kinase Inhibitors -resistant Chronic Myeloid Leukemia Patients in the US
SUZHOU, China and ROCKVILLE, Md., July 22, 2019 /PRNewswire/ -- Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, hepatitis B virus and age-related diseases, today announced that the company was notified by the U.S. Food ...
2019-07-22 07:00
3049
Celltrion and Nan Fung Group to establish Vcell Healthcare Limited to Develop and Commercialize Biosimilars in China
INCHEON, South Korea and HONG KONG, July 19, 2019 /PRNewswire/ -- Celltrion and Nan Fung Group announced today the establishment of Vcell Healthcare Limited, a Joint Venture company between both parties. At the formation of the Joint Venture, Vcell Healthcare Limited has simultaneously signed a ...
2019-07-19 08:00
3864
Janssen Korea Ltd. and Johnson & Johnson Innovation Announce Launch of Seoul Innovation QuickFire Challenge in Smart Healthcare in Collaboration with Seoul Metropolitan Government and Korea Health Industry Development Institute
- QuickFire Challenge seeks to identify and accelerate game-changing, early-stage health tech innovations from around the world. - Awardees will receive up to KRW150,000,000 (approximately US $134,000), residence at the Seoul Bio Hub, mentorship and coaching, and access to the Johnson & Johnson...
2019-07-18 07:00
4245
Yuyu Pharma Receives Recognition for Outstanding Company Culture in Korea
SEOUL, South Korea, July 17, 2019 /PRNewswire/ -- Yuyu Pharma has received recognition as a Great Place to Work from the mayor of Jechoen city. The company also supported a recent HeForShe movement sponsored by the city of Jechoen. HeforShe is an UN-led gender equality movement that focuses on th...
2019-07-17 21:00
2594
The Menarini Group Celebrates the Champions of Fair Play
FLORENCE, Italy, July 16, 2019 /PRNewswire/ -- Two days dedicated to sport and the greater values of Fair Play. Last July the city ofFlorence hosted the XXIII^ edition of the International Fair Play Menarini Award: the annual event which celebrates those sporting champions who have stood out in t...
2019-07-16 15:00
3834
Merck's Embracing Carers™ Launches 'Time Counts' to Raise 1 Million Minutes of Support for Carers
DARMSTADT, Germany, July 16, 2019 /PRNewswire/ -- Merck, a leading science and technology company, today announced that its Embracing Carers™ initiative has launched 'Time Counts,' a social media-led video series asking friends and families of carers to collectively give 1 million minutes of thei...
2019-07-16 15:00
2755
Cipla EU and Jiangsu Acebright Enter Into Joint Venture
MUMBAI & JIANGSU, China, July 16, 2019 /PRNewswire/ -- Cipla (EU) Limited, ("Cipla EU"), a U.K.-based wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (hereafter referred to as "Cipla") and Jiangsu Acebright Pharmaceutical Co. Ltd....
2019-07-16 11:22
6009
Week's Top Stories
Most Reposted
Tan Xuguang: Enter South Korea, Full Focus on Business in the "Doorstep" Market
[Picked up by 328 media titles]
2024-06-16 19:38
Rising Through the Ranks: Giti Recorded as the Fastest-Growing Tire Brand in the World, and They Are Not Stopping There
[Picked up by 311 media titles]
2024-06-12 15:34
Broad-Based ETFs Unleashing Opportunities to Invest in China A-Shares Amid Market Recovery
[Picked up by 238 media titles]
2024-06-11 10:06
The Third Hong Kong Science Fair Gathers Creative Technologies of the Next Generation
[Picked up by 231 media titles]
2024-06-10 12:11
Forrester: APAC Tech Spend To Grow 7% Annually, Reaching US $876 Billion In 2027
[Picked up by 224 media titles]
2024-06-11 12:07Most Read
Rising Through the Ranks: Giti Recorded as the Fastest-Growing Tire Brand in the World, and They Are Not Stopping There
2024-06-12 15:34
12668
Broad-Based ETFs Unleashing Opportunities to Invest in China A-Shares Amid Market Recovery
2024-06-11 10:06
11427
Chengdu's influence being felt across the world
2024-06-11 16:44
7503
Global Civilization Initiative conforms to trend, meets demand of times
2024-06-13 17:54
7373
